section name header

Pronunciation

moe-MET-a-sone

Classifications

Therapeutic Classification: corticosteroids, allergy, cold and cough remedies

Pharmacologic Classification: corticosteroids

Indications

REMS


Propel

Sinuva

Action

  • Stabilizes and separates nasal mucosal tissues, prevents obstruction caused by adhesions and decreases edema.
Therapeutic effects:
  • Decreased need for postoperative interventions such as lysis of adhesions and/or the need for corticosteroids.
  • Reduction in nasal obstruction/congestion and quantity of nasal polyps.

Pharmacokinetics

Absorption: Action is local.

Distribution: Unknown.

Metabolism/Excretion: Primarily metabolized in the liver via the CYP3A4 isoenzyme.

Half-Life: Unknown.

Time/Action Profile

ROUTEONSETPEAKDURATION
Implantunknownunknownunknown



Contraind./Precautions

Contraindicated in:

Use Cautiously in:

Adv. Reactions/Side Effects

EENT: epistaxis, nasal perforation

Neuro: headache

Resp: sinusitis, bronchitis

Misc: foreign body reaction, TOXIC SHOCK SYNDROME

Interactions

Drug-drug:

Route/Dosage

Availability

Assessment

Implementation

Patient/Family Teaching

Evaluation/Desired Outcomes

US Brand Names

Sinuva